Erasca (ERAS) Earnings Date & Reports

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ERAS is expected to report earnings to rise 15.55% to -12 cents per share on May 08

Q1'25

Est.

$-0.13

Q4'24

Beat

by $0.02

Q3'24

Beat

by $0.06

Q2'24

Missed

by $0.11

Q1'24

Missed

by $0.03

The last earnings report on March 20 showed earnings per share of -10 cents, beating the estimate of -12 cents. With 267.40K shares outstanding, the current market capitalization sits at 390.91M.

View a ticker or compare two or three

Compare

ERAS